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Abstract
Background: A randomized control trial was performed to test whether a lifestyle intervention program, carried
out in a primary healthcare setting using existing resources, can reduce the incidence of type 2 diabetes in
Japanese with impaired glucose tolerance (IGT). The results of 3 years’ intervention are summarized.
Methods: Through health checkups in communities and workplaces, 304 middle-aged IGT subjects with a mean
body mass index (BMI) of 24.5 kg/m
2 were recruited and randomized to the intervention group or control group.
The lifestyle intervention was carried out for 3 years by public health nurses using the curriculum and educational
materials provided by the study group.
Results: After 1 year, the intervention had significantly improved body weight (-1.5 ± 0.7 vs. -0.7 ± 2.5 kg in the
control; p = 0.023) and daily non-exercise leisure time energy expenditure (25 ± 113 vs. -3 ± 98 kcal; p = 0.045).
Insulin sensitivity assessed by the Matsuda index was improved by the intervention during the 3 years. The 3-year
cumulative incidence tended to be lower in the intervention group (14.8% vs.8.2%, log-rank test: p = 0.097). In a
sub-analysis for the subjects with a BMI > 22.5 kg/m
2, a significant reduction in the cumulative incidence was
found (p = 0.027).
Conclusions: The present lifestyle intervention program using existing healthcare resources is beneficial in
preventing diabetes in Japanese with IGT. This has important implications for primary healthcare-based diabetes
prevention.
Trial registration number: UMIN000003136
Background
The incidence of type 2 diabetes is increasing in Japan
[1]. Although Japanese have a lower prevalence of obe-
sity than Westerners, a tendency to gain weight due to
lifestyle changes coupled with an aging of the population
seems to be closely related to the rapid expansion of the
diabetic population [1]. There is thus an urgent need for
effective public health strategies to combat this situation
in Japan.
There is now substantial evidence that the development
of type 2 diabetes can be prevented or delayed in high-
risk subjects through lifestyle intervention [2-8]. The
Finnish Diabetes Prevention Study (DPS) [4] and the US
Diabetes Prevention Program (DPP) [5] have clearly
shown that, in obese subjects with impaired glucose tol-
erance (IGT), lifestyle changes associated with a 5-7%
decrease in body weight resulted in a 58% reduction in
the development of diabetes. Thus lifestyle modifications
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preventing the development of type 2 diabetes. There are
several examples in the literature about the various levels
of effectiveness of lifestyle intervention [9]. In both the
DPP [5] and DPS [4], considerable efforts were made by
well-trained staff to achieve changes in lifestyle among
participants. However, results are not consistent across
studies in primary healthcare settings. How to translate
the findings of clinical research, such as the DPS and
DPP, into real-world practice [10,11] is a key issue to be
addressed. In Japan, by law, much of the adult population
undergoes a health checkup every year in the workplace
or at community centers. The checkups have revealed a
huge number of subjects at a high risk for developing
type 2 diabetes. These people are usually given simple
information and guidance about diabetes and a healthy
lifestyle. Despite this approach, the diabetic population
has increased at the national level, probably due to a lack
of evidence-based methodologies of lifestyle intervention
and mechanisms to implement these widely at public
health care levels. It is not known to what extent lifestyle
intervention in a primary healthcare setting is effective.
The present study is a randomized control trial to test
the feasibility and effectiveness of a lifestyle intervention
program, carried out in a primary healthcare setting
using existing resources, in Japanese with IGT. We found
that this relatively modest intervention could produce
beneficial effects on the incidence of type 2 diabetes over
a 3-year period. This has important implications for pri-
mary healthcare-based diabetes prevention.
Methods
The study protocol was approved by the Ethics Commit-
tee of the National Hospital Organization Kyoto Medical
Center, and all subjects gave their written informed con-
sent before the start of the study. Thirty-two community
health care institutions and company clinics across the
country participated in the study as collaborative centers.
In each center, a public health nurse was appointed as a
study nurse for recruitment, intervention, laboratory
referral, and clinical measurements.
Study design and subjects
Subjects with IGT, aged 30-60 years, were recruited
through health checkups conducted at each collabora-
tive center. The recruitment started in March 1999 and
was completed in December 2002. A two-step strategy
was adopted for identifying subjects with IGT as
d e s c r i b e dp r e v i o u s l y[ 1 2 ] .U s i n gt h ed a t af r o mh e a l t h
checkups, those who met one of the following criteria
were extracted: 1) fasting plasma glucose (FPG) concen-
tration ≥5.6 mmol/l but < 7.0 mmol/l, 2) casual
plasma glucose (CPG) concentration ≥7.8 mmol/l but
<11.1 mmol/l when blood is drawn within 2 hours after
a meal, or CPG concentration ≥6.1 mmol/l but
<7.8 mmol/l when blood is drawn 2 hours or more after
a meal, or 3) IGT as indicated by a previous 75 g oral
glucose tolerance test (OGTT). Those with 1) a previous
diagnosis of diabetes mellitus other than gestational dia-
betes, 2) a history of gastrectomy, 3) physical conditions
such as ischemic heart disease, heart failure, exercise-
induced asthma, and orthopedic problems where exer-
cise was not allowed by a doctor, 4) definitive liver and
kidney diseases, 5) autoimmune diseases, and 6) a habit
of drinking heavily (69 g or more of ethanol per day)
[13] were excluded. Those who had already begun life-
style modifications, such as routine moderate to vigor-
ous exercise, were also excluded. Thus it should be
noted that the findings obtained cannot be generalized
to all high-risk people with IGT. It was roughly esti-
mated that there were more than 10,000 people with
borderline hyperglycemia at the 32 collaborative centers.
Each center recruited study candidates using posters,
through fliers, and by word of mouth. Figure 1 shows a
flow diagram for recruiting study subjects. Altogether,
1279 subjects who met the criteria and gave written
informed consent, underwent a 75 g OGTT. Diabetes
and IGT were diagnosed based on the World Health
Organization (WHO)’s criteria [14].
Finally, 304 subjects diagnosed with IGT were ran-
domly assigned to either a lifestyle intervention group
or a control group by the committee of the study group.
Two subjects from the control group and 6 from the
i n t e r v e n t i o ng r o u pw e r ee x c l u d e df r o mt h es t u d y ,s i n c e
it turned out that they did not meet the eligibility cri-
teria. The result of the randomization was unmasked to
the participants, those administering the interventions,
and those assessing the data. The average number of
participants per center (including both the control and
intervention groups) was 9. We planned to follow-up
the participants for 6 years regarding the development
of diabetes.
According to prospective studies on the Japanese
population, the yearly incidence of diabetes among
subjects with IGT varies between 1 and 5% [15-17].
Therefore, it was assumed that the 6-year cumulative
incidence of diabetes would be 30% in the control
group. The present study was designed to detect a 50%
reduction in the incidence by the intervention. Thus
t h es a m p l es i z er e q u i r e dw a s3 1 3w i t hat y p e1e r r o r
of 5%, with 80% power (beta = 20%) at the two-tailed
5% significance level, and allowing for a withdrawal
rate of 30%.
Intervention
The follow-up of the participants started in April 1999
and the last case completed a three-year follow-up in
January 2006.
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Page 2 of 8The goals of intervention were: 1) to reduce initial
b o d yw e i g h tb y5 %i no v e r w e i g h ta n do b e s es u b j e c t s ,
and 2) to increase energy expenditure due to leisure
time physical activity (LTPA) by 700 kcal per week. The
interventions were carried out by the study nurse in
each collaborative center in the form of both group and
individual sessions, using the guideline, curriculum, and
educational materials provided by the committee of the
study group. When needed, the study nurse could ask a
part-time dietician for diet counseling. A 27-page book-
let titled “Change Your Lifestyle to Prevent Diabetes”
was given to each participant as a guide. During the
initial six months, four group sessions were conducted
using slides, videotapes, and a booklet with each session
lasting two or three hours. The main subjects in each
group session were as follows: (1) What is diabetes?,
What is IGT?, How to prevent diabetes?, (2) Healthy
diets to prevent diabetes, (3) Exercise tips to prevent
sporting injuries, and (4) Let’s enjoy exercise. The indi-
vidual session was conducted biannually during the
three years with each session lasting 20 to 40 minutes.
Personalized goals, such as a minimum of 20 minutes’
moderate walking each day, were set. The session was
conducted based on theoretical concepts and techniques
for behavioral change, such as self-efficacy, self-monitor-
ing, and the transtheoretical model [18]. After the first
year, contact by telephone could replace the individual
face to face sessions. The study subjects attended both
group and individual sessions by themselves without any
support person.
An assessment of the dietary intake of each participant
was conducted using a semiquantitative food frequency
questionnaire (FFQ) [19] with photographs of 122 vari-
eties of dishes and foods. Each item was shown with a
real portion size. The subjects were advised to take the
proper amount of calories, decrease the mean percent of
energy derived from dietary fat to less than 25%, and
restrict daily alcohol consumption to less than 160 kcal.
They were also advised to eat three meals a day and
avoid eating late at night. Self-reported levels of LTPA
were assessed using a physical activities questionnaire
[20]. To achieve the exercise goal, aerobic exercise such
as walking was recommended. Data on dietary intake
and physical activities were assessed by the study group
and the results were sent back to study nurses at each
collaborative center.
To reinforce the intervention, between-visit contact by
fax was also made monthly during the initial twelve
Prescreening using data form heath checkups
1279 assessed for eligibility and screened using 75g OGTT
304 randomized
Excluded (n=975); 
DM (n=192), IFG (n=110), NGT (n=638).
IGT but did not meet eligibility criteria (n=35)
Assigned to control group (n=152) Assigned to intervention group (n=152)
Completed 3-years follow-up (n=110)
Excluded (n=2);
did not meet eligible criteria (n=1)
withdrew informed consent (n=1)
Discontinued during 
3 years (n=40)
Excluded (n=6); 
did not meet eligible criteria (n=6)
Discontinued during  
3 years (n=43)
Available for follow-up study (n=150) Available for follow-up study (n=146)
Completed 3-years follow-up (n=103)
Figure 1 Recruitment, random assignment, and 3 - year follow-up of study subjects. DM: diabetes mellitus, IFG: impaired fasting glucose,
NGT: normal glucose tolerance.
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give tips for improving lifestyle.
The control group received only one group session on
a healthy lifestyle and the prevention of diabetes at the
baseline. No individual guidance was given during the
study period. However, the control group received
anthropometric and blood examinations regularly during
the study as did the intervention group.
Measurements
Anthropometric (height, body weight, and waist circum-
ference) and blood pressure measurements were done
every three months during the first year and biannually
thereafter. Waist circumference was measured at the
umbilical level. Biochemical studies, including a 75 g-
OGTT, were conducted biannually during the first year
and annually thereafter. Total cholesterol, high-density
lipoprotein (HDL)-cholesterol, triglyceride, creatinine,
uric acid, aspartate aminotransferase (AST), alanine ami-
notransferase (ALT), gamma-glutamyltransferase (GGT),
HbA1c, plasma glucose, and insulin levels were mea-
sured at a central laboratory (SRL Co. Ltd.,, Tokyo,
Japan). For the intervention group, the results of these
measurements were given back individually to each sub-
ject in the intervention group during individual sessions
with the study nurse. For the control group, the results
were sent by mail with brief comments. The assessment
of dietary intake was conducted annually. Levels of
LTPA were assessed biannually during the first year and
annually thereafter. Pancreatic b cell function and insu-
lin resistance were assessed using the homeostasis
model assessment (HOMA-b and HOMA-IR, respec-
tively) [21]. An insulin sensitivity index (Matsuda index)
was also calculated using insulin and glucose data
obtained from 75 g OGTTs [22,23]. Body mass Index
(BMI) was calculated as weight in kilograms divided by
height in meters squared. “Overweight” and “obese”
were defined according to the WHO recommendations
for Asians [24]. All clinical and diet and exercise data
were collected at each collaborative center by the study
nurse and sent to the study group for analysis.
Endpoint
The primary endpoint was the development of diabetes,
diagnosed and confirmed by two consecutive 75 g-
OGTTs. The diagnosis of diabetes was based on the
WHO’s criteria [14].
Training of the study nurses
The study group organized a one and a half day study
meeting for the study nurses in the beginning and
annually thereafter. The meeting was designed to 1)
standardize the intervention method, 2) improve their
skills for eliciting motivation from the participants to
achieve the lifestyle goals, and 3) increase their knowl-
edge on diabetes, nutrition, exercise, and behavioral
modification. The attendance rate for the nurses was
almost 100% in the initial training course and between
70 and 90% for the annual training course after 1 year.
Statistical analysis
All data are presented as the means ± SD. Compari-
sons of baseline values and mean changes from base-
line to year 1 between the groups were made with a
two-tailed unpaired t test or the c
2 test when applic-
able. A two-tailed paired t-test was used to analyze dif-
ferences within groups between the baseline and year
1. Survival curves were calculated to estimate the
cumulative incidence of diabetes. The difference
between the groups in the incidence of diabetes
was tested by means of the two-sided log-rank test.
A p value less than 0.05 was considered statistically
s i g n i f i c a n t .T h ea n a l y s e sw e r ed o n eu s i n gt h eS P S S / P C
statistical program (version 11.1 for windows; SPSS,
I n c . ,C h i c a g o ,I L ,U S A ) .
Results
We randomly assigned the 304 subjects with IGT to two
groups and analyzed the data for 296 individuals (150 in
the control group and 146 in the intervention group)
(Figure 1). A total of 83 subjects (28%) withdrew from
the study before the 3-year mark (40 in the control group
and 43 in the intervention group). The withdrawals were
due to personal reasons (moving etc) in 18 cases, medical
reasons in 5, and loss of contact in 40. Twenty subjects
were not able to continue the study for reasons related to
the collaborative centers themselves, such as the closure
of a center. The rate of withdrawal was higher among
men than women (36.9% vs. 19.0%, p < 0.01). No differ-
ences were found in age and BMI between those who
withdrew from the study before the 3-year mark and
those who continued. The baseline characteristics of both
the control and intervention groups were similar as
regard to age (51 ± 6 and 51 ± 7, respectively) and male
to female ratio (76/74 and 74/74, respectively), and pro-
portion of overweight (23.0≤BMI<27.4: 48.5% and 50.0%,
respectively) and obese (BMI ≥27.4: 18.6% and 18.8%,
respectively) people. There was no difference in exercise
LTPA between the groups at the baseline (p = 0.197),
although non-exercise LTPA (below 3 METs) was signifi-
cantly greater in the control group (p = 0.043). Non-
exercise LTPA included gardening, shopping, Sunday
carpentering, playing musical instruments, and so on.
There were no significant differences in other lifestyle,
anthropometric, and biochemical measurements at the
baseline between the groups (Table 1). Thus we were
able to successfully assign the cohort of subjects to two
groups.
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metric, and biochemical parameters from the baseline
at the 1-year and 3-year marks in both groups. In the
intervention group, the mean daily energy intake
decreased by 202 kcal and mean daily energy expendi-
ture by LTPA increased by 64 kcal at the 1-year mark.
These beneficial lifestyle changes were observed even at
the 3-year mark. Body weight, BMI, waist circumference,
and systolic and diastolic blood pressure (not shown in
the Table 1) decreased significantly from the baseline at
the 1-year mark. The changes in body weight and BMI
were seen also at the 3-year mark.
Although fasting and 2 hour plasma glucose
decreased, fasting and 2 hour insulin concentrations did
not change during the three years. HOMA-IR and
HOMA-b did not change either (data not shown). How-
ever, Matsuda index, as a marker of whole body insulin
sensitivity calculated using plasma glucose and serum
insulin levels from 75 g OGTTs, increased from the
baseline at both the 1-year and 3-year marks. Serum
GGT levels decreased at the 1-year mark. Serum HDL
cholesterol levels increased at the 1-and 3-year marks
while serum triglyceride and cholesterol levels did not
change (data not shown). Beneficial changes were also
found in the control group although to a lesser extent.
Between the groups, changes in daily energy expenditure
due to non-exercise LTPA, body weight and BMI, serum
GGT levels, and the Matsuda index were significantly
different at the 1-year mark. These differences were not
significant at the 3-year mark except for the Matsuda
i n d e x .T h ed i f f e r e n c ei nt h eM a t s u d ai n d e xr e m a i n e d
significant even at the 3-year mark.
Diabetes was diagnosed in a total of 27 subjects during
the three years; 9 in the intervention group and 18 in the
control group. The estimated cumulative incidence of dia-
betes over the 3-year period was 8.2% in the former and
14.8% in the latter. The relative risk reduction was thus
53% with the intervention [95% confidence interval (CI);
0.25-1.13]. The difference between the groups, however,
did not reach a level of statistical significance (log-rank
test: p = 0.097) at the 3-year mark (Figure 2). Our study
group included both lean and obese subjects with a BMI
ranging widely from 16.8 to 39.6 kg/m
2. It may be thus
possible that the heterogeneity in BMI in our cohort
accounts for the statistically insignificant results. To exam-
ine if the effects of lifestyle intervention alter with BMI,
the participants were then stratified into quartiles accord-
ing to the baseline BMI. Diabetes developed in 5 out of
52 in the lowest quartile (2 from the control group and 3
from the intervention group) during the 3 years. Thus the
effect of lifestyle intervention was not apparent in this low-
est BMI quartile. The sub-analysis for the subjects with a
BMI>22.5, however, revealed a significant decrease in the
cumulative incidence with the intervention (log-rank test:
Table 1 Baseline and 1-year or 3-year follow-up data in the control and intervention groups
Parameters Control group Intervention group P value
b
Baseline
a
(n = 131)
1-year
(n = 131)
3-year
(n = 110)
Baseline
(n = 123)
1-year
(n = 123)
3-year
(n = 103)
at 1-year
mark
at 3-year
mark
Energy intake (kcal) 2455 ± 838 2292 ± 739* 2153 ± 734* 2299 ± 788 2097 ± 895* 2016 ± 677* 0.647 0.794
Fat
c (%) 27.5 ± 5.2 27.4 ± 5.2 27.8 ± 5.4 26.5 ± 5.6 25.5 ± 5.6* 25.7 ± 5.2 0.088 0.110
Alcohol (g) 21.0 ± 36.1 18.6 ± 29.2 13.7 ± 23.2* 20.1 ± 44.8 24.6 ± 87.7 15.7 ± 29.8 0.171 0.149
Leisure time physical activity (kcal) 136 ± 159 163 ± 172* 181 ± 201* 91 ± 132 155 ± 180* 161 ± 215* 0.078 0.214
Exercise (kcal) 57 ± 79 86 ± 99* 92 ± 105* 43 ± 88 82 ± 122* 74 ± 117* 0.474 0.958
Exercise (minutes per week) 118 ± 160 184 ± 206* 185 ± 229* 91 ± 187 184 ± 262* 160 ± 229* 0.339 0.556
Non-exercise (kcal)
d 79 ± 139 76 ± 133 90 ± 174 49 ± 85 74 ± 119* 88 ± 186* 0.045 0.148
Weight (kg) 63.9 ± 11.7 63.1 ± 11.7* 62.5 ± 11.2* 64.9 ± 12.9 63.5 ± 12.9* 63.1 ± 12.9* 0.023 0.069
Body mass index (kg/m
2) 24.5 ± 3.2 24.2 ± 3.1* 24.4 ± 3.3* 24.8 ± 3.6 24.2 ± 3.6* 24.3 ± 3.7* 0.022 0.051
Waist circumference (cm) 84.4 ± 9.4 83.3 ± 8.6* 84.2 ± 9.5 85.9 ± 10.9 84.2 ± 10.5* 84.7 ± 11.9 0.309 0.362
Fasting plasma glucose (mmol/l) 6.1 ± 0.5 5.9 ± 0.6 6.0 ± 0.9 5.9 ± 0.5 5.8 ± 0.6* 6.0 ± 0.8 0.698 0.481
2-hplasma glucose (mmol/l) 9.0 ± 0.9 8.3 ± 2.0* 8.5 ± 2.4 9.2 ± 0.9 8.0 ± 2.1* 8.4 ± 2.5* 0.083 0.553
Fasting insulin (pmol/l) 43.8 ± 21.6 44.4 ± 40.8 45.8 ± 23.9 43.2 ± 22.2 44.4 ± 25.2 47.6 ± 36.1 0.861 0.632
2-h insulin (pmol/l) 330.6 ± 211.8 308.4 ± 178.8 377.4 ± 280.7 337.8 ± 199.8 342.0 ± 271.2 390.0 ± 374.2 0.413 0.999
Matsuda index
e 5.4 ± 3.5 5.6 ± 3.3 5.3 ± 3.2 4.8 ± 2.3 5.9 ± 3.7* 5.5 ± 3.4* <0.001 <0.001
Aspartate aminotransferase (IU/l) 25 ± 8 25 ± 12 26 ± 15 25 ± 12 23 ± 13 25 ± 17 0.170 0.977
Alanine aminotranseferase (IU/l) 25 ± 16 26 ± 17 27 ± 16 26 ± 18 24 ± 17 25 ± 14 0.212 0.520
Gamma-glutamyltransferase (IU/l) 53 ± 58 59 ± 91 59 ± 97* 48 ± 46 44 ± 47* 43 ± 66 0.041 0.158
Data are means ± SDs.
aThere were no significant differences in any of the baseline variables between the control and intervention groups except for non-
exercise physical activity.
bP values for differences in change between groups.
cProportion of energy derived from dietary fat.
dNon-exercise leisure time physical
activity includes gardening, carpentry, shopping, and playing a musical instrument.
eThe Matsuda index is an insulin sensitivity index derived from oral glucose
testing. * P value < 0.05 (Baseline vs. 1-year or 3-year).
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Page 5 of 8p = 0.027). There was no difference in changes in BMI,
waist circumference, and serum lipid levels between the
lowest BMI quartile and the upper BMI quartiles in the
intervention group. The change in serum ALT was signifi-
cantly improved in the upper 3 BMI quartiles than the
lowest BMI quartile at the 1-year mark (-3 ± 16 IU/l vs.
+3.0 ± 9 IU/l; p = 0.010), although there was no difference
in the control group (+1 ± 14 IU/l vs. 0 ± 15 IU/l; p =
0.498). The Matsuda index of the upper 3 BMI quartiles in
the intervention group was significantly improved than in
the control group at the 1-year mark (+1.1 ± 3.0 vs. -0.2 ±
3.6; p = 0.026), although there was no difference in the
lowest BMI quartile between groups (+1.3 ± 3.4 vs. +1.0 ±
3.7; p = 0.702).
Discussion
This is the first randomized control trial to test whether
a lifestyle intervention, carried out on a community or
workplace basis using existing healthcare resources, can
prevent or delay the development of type 2 diabetes in
middle-aged Japanese with IGT.
The participants were recruited through health check-
ups at community health centers and in the workplace.
They were all volunteers, who participated in response
to posters, fliers, and word of mouth. Therefore it was
likely that they were motivated and prepared to alter
their lifestyle, at least in the beginning. The rate of with-
drawal before the 3-year follow-up was, however, high
(28%). About one third of male participants withdrew
from the study. This might represent the limitations of
intervention carried out in a primary healthcare setting.
Generally speaking, middle-aged men in Japan tend to
prioritize work over health. Therefore, modifying life-
style among the middle-aged was a challenge.
Compared with the DPS [4] and DPP [5], the present
study had a less intensive intervention. The majority of
the public health nurses, reflecting the real world pri-
mary healthcare setting, did not have special training in
lifestyle modifications. At a feasible level, they carried
out the intervention using the protocol and educational
materials provided by the study group. As a rule, the
same study nurse carried out the interventions on the
same participant during the study. But this was not
always possible due to a personnel change at the colla-
borative center.
We found improvements in lifestyle and anthropologi-
cal and biochemical parameters with the intervention.
However, between the intervention and control groups,
differences in changes from the baseline were statisti-
cally significant only in increases in energy expenditure
d u et on o n - e x e r c i s eL T P A ,i nw e i g h tr e d u c t i o na n d ,
among biochemical parameters, in serum GGT levels
and the Matsuda index. The mean body weight reduc-
tion was very modest, being 1.5 ± 2.7 kg (2.3%) in the
intervention group and 0.7 ± 2.5 kg (1.3%) in the con-
trol group at the 1-year mark. At the 3-year mark, the
differences between the groups were not statistically sig-
nificant for any of the parameters except the Matsuda
index. Thus it was suggested that the improvement in
insulin sensitivity assessedb yt h eM a t s u d ai n d e xw a s
maintained during the three years.
In this study, four group sessions were given to the
intervention group during the initial 6 months, while
one session was given to the control group about dia-
betes mellitus and a healthy lifestyle at the baseline. The
control group, however, underwent physical and blood
examinations regularly during the study as did the inter-
vention group. In addition, as the study subjects were
individually randomized at each collaborating center,
exchanges of information among participants at the
same collaborative centers could have happened. All
these factors might lead to difficulties in obtaining sta-
tistically significant differences between the groups.
Therefore, it would be more appropriate to refer to the
groups as a conventional intervention group and an
intensive intervention group instead of a control group
and an intervention group, respectively.
Most importantly, we found that this relatively modest
intervention could produce beneficial effects on the inci-
dence of type 2 diabetes during a 3-year period. The
halving (51%) of the relative risk for overall subjects
through this intervention is not negligible, even though
it did not reach a statistically significant level. Our
cohort was heterogeneous in BMI with 30% of the sub-
jects having a normal or lower than normal BMI. Due
to the small number of subjects in the present study, a
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Figure 2 Cumulative incidence of diabetes over the three years
in all participants. Kaplan-Meier plots. Intervention group (black
circle) and Control group (black triangle).
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Page 6 of 8subgroup analysis was difficult. But we found a signifi-
cant reduction in cumulative incidence (log-rank test: p
= 0.027) for the subjects with a BMI> 22.5. Thus the
effects of the intervention for lean subjects might
attenuate the impact on the incidence. Regarding this, it
would be important to clarify an effective measure for
the prevention of diabetes in subjects with a low BMI in
future studies, since the Japanese IGT population
includes a considerable number of such subjects.
In the DPP, weight reduction was found to be essen-
tial for the lifestyle intervention to be beneficial [5]. In
an Indian Study [7], however, the benefits seemed inde-
pendent of weight change. In a hospital-based lifestyle
intervention, Kosaka concluded that the benefits of life-
style intervention could not be solely ascribed to weight
reduction [6]. The present study found that minimal
weight reduction in the intervention group (less than 3%
on average) lowered the relative risk to 53% over
3 years, similar to the risk reduction seen in the DPS
and DPP (58%) where the subjects lost 5-7% of body
weight on average. Thus it seems that the relationship
between body weight and diabetes risk in Asians is not
as straightforward as in Western people. Asians have
lower BMI but higher body fat levels than do whites
[25,26]. Japanese Americans are prone to develop visc-
eral obesity and metabolic syndrome [27,28]. A reason-
able explanation for the present findings might be a
more profound reduction in specific fat depots, such as
visceral fat and liver fat. It has been reported that life-
style intervention with diet and physical activity is effec-
tive at reducing hepatic steatosis in patients with non-
alcoholic fatty liver disease [29]. Although there was no
difference in daily alcohol consumption between the
groups, we found that serum GGT levels decreased in
the intervention group, but increased in the control
group. These findings are important, since it has been
reported that the serum concentrations of GGT and
ALT are a predictive marker of type 2 diabetes [30-33],
even at concentrations still considered to be within the
normal range [34]. Thus, the difference in the changes
in GGT levels between the groups is likely to reflect
changes in liver fat contents. Further examination
including abdominal ultrasonography and computed
tomography [35] will be needed.
Conclusions
In conclusion, the present study suggests that lifestyle
intervention using existing healthcare resources in com-
munities and workplaces is beneficial in preventing or
delaying the development of diabetes in middle aged
Japanese with IGT. General improvements in lifestyle
including dietary and exercise habits might be meaning-
ful even if the weight reductions achieved are only
modest. The findings have important implications for
primary healthcare-based diabetes prevention.
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